Recursion plans to present updated data from the TUPELO trial in an upcoming webinar scheduled for December 8, 2025. This presentation will provide further insights into the drug’s safety and efficacy ...
Abstract: Around 1.3 billion, or more than 15% of the global population, suffer from a significant form of disability, with students and researchers in this category being underrepresented in higher ...
Rob Cesternino (@robcesternino) and Akiva Wienerkur (@keev26) need a podcast and every week, Rob and Akiva spin a wheel of listener-submitted podcast ideas, and whatever the wheel lands on is what ...
Alzheimer’s has long been considered irreversible, but new research challenges that assumption. Scientists discovered that severe drops in the brain’s energy supply help drive the disease—and ...